Hypera Stock

Hypera Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Hypera (HYPE3.SA) as of Aug 15, 2026 is 215.37 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 189.38 % — a change of 13.72% (higher).

Cash Conversion

215.37 %

YoY

13.72%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Hypera is 2026 215.37 % . Cash Conversion Rate (OCF/Net Income) of Hypera was 2025 189.38 % . It decreases by 13.72% higher compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Cash Conversion Rate (OCF/Net Income) of Hypera is 215.37 % in 2026.

Cash Conversion Rate (OCF/Net Income) of Hypera changed from 189.38 % to 215.37 %, representing a 13.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Hypera since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Hypera with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

Cash Flow — Hypera

All Key Metrics — Hypera